Phibro Animal Health Corporation
PAHC
$43.37
$1.313.12%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 27.37% | 19.12% | 12.63% | 7.17% | 4.07% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.37% | 19.12% | 12.63% | 7.17% | 4.07% |
| Cost of Revenue | 26.49% | 15.80% | 10.09% | 5.59% | 3.59% |
| Gross Profit | 29.34% | 26.75% | 18.44% | 10.78% | 5.16% |
| SG&A Expenses | 9.15% | 23.59% | 19.96% | 17.25% | 28.65% |
| Depreciation & Amortization | -20.46% | -1.94% | -1.94% | -1.94% | -1.94% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.85% | 14.49% | 9.34% | 4.58% | 5.31% |
| Operating Income | 110.20% | 87.26% | 61.64% | 48.67% | -11.56% |
| Income Before Tax | 522.87% | 94.82% | 20.11% | -11.34% | -79.81% |
| Income Tax Expenses | 132.11% | 46.73% | 8.54% | -5.21% | -60.40% |
| Earnings from Continuing Operations | 1,897.68% | 141.54% | 30.53% | -16.05% | -92.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1,897.68% | 141.54% | 30.53% | -16.05% | -92.59% |
| EBIT | 110.20% | 87.26% | 61.64% | 48.67% | -11.56% |
| EBITDA | 80.85% | 63.83% | 44.38% | 33.02% | -5.86% |
| EPS Basic | 1,895.64% | 141.45% | 30.51% | -16.04% | -92.58% |
| Normalized Basic EPS | 330.74% | 141.09% | 59.65% | 25.87% | -60.89% |
| EPS Diluted | 2,010.34% | 141.82% | 31.21% | -16.42% | -93.03% |
| Normalized Diluted EPS | 329.60% | 140.18% | 59.23% | 25.69% | -60.97% |
| Average Basic Shares Outstanding | 0.01% | 0.01% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.36% | 0.36% | 0.25% | 0.12% | 0.07% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.95% | -0.59% | -0.23% | 0.19% | 12.50% |